SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-053389
Filing Date
2017-10-20
Accepted
2017-10-20 11:13:49
Documents
2
Period of Report
2017-11-28
Effectiveness Date
2017-10-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv477059_def14a.htm DEF 14A 670517
2 GRAPHIC arrow.jpg GRAPHIC 1006
  Complete submission text file 0001144204-17-053389.txt   673134
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-54495 | Film No.: 171146305
SIC: 2834 Pharmaceutical Preparations